People
Membership into this academy is one of the highest honors in health and medicine
Chief Executive Officer Scott Shively said the acquisition of an oral analgesic from Johnson & Johnson will be transformative for California-based Neumentum Inc.
Here are some of the top biotech influences of this generation.
Achilles Therapeutics, a biopharmaceutical company developing personalised cancer immunotherapies, announces it has appointed Beverley Carr as Chief Business Officer, with effect from 4 November 2019.
When it comes to specific attributes, having the opportunity to do interesting and meaningful work, securing a competitive salary and having access to quality health benefits were the most important. Here are some differences when it comes to generational priorities.
Plexium is focused on developing therapeutics that influence E3 ligases that can degrade proteins, even the undruggable ones. The company’s founder and chief executive officer Kandaswamy “Swamy” Vijayan, took time out to speak with BioSpace about the company and its technology platform, DELPHe.
According to the report, the majority of the cuts will occur in the company’s Human Health Division and are expected to begin Jan. 3 and conclude Jan. 16, 2020.
HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver diseases announced the appointment of seasoned biotech expert Dr. Michael Lutz as new CEO and Managing Director of the company..
Pharma, biotech and medtech companies strengthen their executive ranks and boards with this week’s Movers & Shakers.
Reenie McCarthy, chief executive officer of Stealth Biotherapeutics, has seen first-hand the negative impact of mitochondrial diseases, including watching an athlete decline from being an Olympic-level rower to becoming wheelchair-bound.
PRESS RELEASES